Loading…
Loading…
Framatome is a French nuclear-energy company — majority-owned by EDF S.A.
Named counterparties identified by open-source research and written only where a primary source states the relationship — never inferred from sector or co-mention. 1 customer-side. This is a partial view: it covers the relationships we could evidence, not the company's full supply base.
Four European VVER-440 operating utilities (Czech Republic, Finland, Hungary, Slovakia) contracted with Framatome to co-develop its sovereign European VERA-440 fuel assembly design and transport container, targeting first own-design lead fuel assemblies from 2028; long-term fuel-supply diversification agreement.
Scope. Absence of a counterparty here is not evidence that none exists — most commercial sourcing is confidential and never becomes public. Rows without a share figure mean no share was disclosed, not that the relationship is small.
Another tracked dossier names this company as a counterparty in its own sourced disclosure — this platform never wrote these rows on this company's own page, they are read here inverted from the dossier that disclosed them. This is a partial view: 986 additional named-counterparty rows across the corpus could not be matched to a tracked dossier by name at all (mostly non-Latin legal names), so the true count is higher than what renders here.
Eskom IR 2025 (Ensuring Koeberg continuity through nuclear fuel security) says existing contracts with Westinghouse and Framatome ensured uninterrupted delivery of fabricated nuclear fuel, with volumes secured through end-2025; a new fuel-fabrication procurement cycle is being initiated. Receiving plant is Koeberg (Western Cape, ZA). The report names no fabrication plant or country and no amount; WNN (2023) said Koeberg 2 fuel comes from Framatome in France, but the 2025 source does not pin origin, so the flow is left unpinned.
Scope. This section is inverted evidence: each linked dossier wrote the original row about itself, describing its own relationship to this company. It is never a claim this company itself disclosed. Absence here is not evidence of no relationship — most of the corpus has no named-counterparty block at all yet.
Every exposure is read as a buyer dependency; the top 3 are its binding chokepoints.
As a buyer, policy pressure across its consumed materials is flat.
Descriptive trend in official policy actions on this company’s materials — a policy-pressure trend, not a price or trading signal. No forward probability is implied. Direction is measured on actions we have discovered, and discovery lags events: where the recent window is too thin to support a calm reading, the row says coverage-limited instead of easing.
No actions in the register have named or swept this company in the last 24 months.